Dr Hui-Peng (Peng) Lee Department of Haematology
Flinders Medical Centre
Dr Peng Lee is a Clinical and Laboratory Haematologist at Flinders
Medical Centre and SA Pathology in Adelaide. She graduated from the
University of Auckland, New Zealand and has dual Fellowship of the Royal
Australasian College of Physicians (RACP) and the Royal College of
Pathologists of Australasia (RCPA). She moved to Australia from NZ in
2007. Furthermore, she is the Lymphoma Lead Clinician at the South
Adelaide Local Health Network, and acts as Principal Investigator for
numerous lymphoproliferative clinical trials conducted at Flinders
Medical Centre. She was the HSANZ Convenor for the first virtual Blood
Conference in 2021. Peng is an active member of the Lymphoma and CLL
Working Parties within the Australasian Leukaemia and Lymphoma Group
(ALLG). In addition, Peng is a member of Australasian Lymphoma Alliance
(ALA), the Haematology Reference Committee for EviQ, Women in Lymphoma
(WiL), New Zealand Women in Medicine (NZ WIM) and the SA Statewide
Haematology Advanced Training Committee. Outside of haematology, Peng
has a young family with a busy husband and two loud children, and runs
(for fitness, and terribly). She has a keen interest in travel and is an
avid single malt appreciator. She remains in the pursuit of the perfect
Work/Life Balance, and she thinks she’s quite nearly achieved it.
Dr Annette Neylon
Department of Medicine (Dunedin)
University of Otago
Dunedin, New Zealand
Neylon completed training in Haematology in Newcastle upon Tyne in
2003, obtaining fellowships of the Royal College of Physicians and Royal
College of Pathologists (UK), as well as completing an MD in the field
of Chronic Myeloid Leukaemia. She worked as a Specialist Haematology and
Lead of the South of Tyne Haematology Specific Tumour Group of the
Northern Cancer Network between 2003 and 2007, before moving to Southern
Blood and Cancer Service in Dunedin, Otago as Clinical Lead of
Haematology. She was admitted as a Fellow of the Royal Australasian
College in 2010. Between 2008 and 2019 she worked as a member of the New
Zealand Ministry of Health Haematology Work Group. She has acted as
Principal Investigator of several clinical research trials. In addition,
Annette was Clinical representative to the South Island NZ DHBs
Clinical Operations Advisory Group and since 2018 has been a member of
the RACP NZ Joint College Training Sub-Committee for Haematology. Her
main areas of interest are in malignant haematology, especially multiple
myeloma and lymphoma. When not working, Annette functions as a taxi
driver, event organiser and side-line cheerleader for her son.
HONORARY MEMBERSHIP DIRECTOR
Dr Matthew (Matt) Wright
Head of laboratory Haematology Department
Fiona Stanley Hospital
Matt Wright is a clinical and lab Haematologist from Fiona Stanley Hospital in Perth.
He completed training in Sydney before enjoying a transplant fellowship in Vancouver, and later a sabbatical in Cambridge focussed on MPN.
His clinical interests are myeloid neoplasms and allotransplant, and he is a passionate teacher of laboratory medicine. Matt is a national examiner for the RCPA and RACP, and enjoys travelling to teach in the Asia-pacific region.
In his spare time Matt likes ocean swimming and losing to his two boys at Golf.
Dr Adam Bryant
Senior Staff Specialist
Adam Bryant is a Senior Staff Specialist at Liverpool Hospital where he has worked since 2012 as a development member of the allogeneic BMT program which commenced at this time. Adam’s other specific subspecialty interest is as a core member of the Liverpool Hospital Myeloma Subspecialty Unit. Adam and his colleagues are responsible for an exceptionally large practice of myeloma patients. This unit has been a strong recruiter for many Phase 2 and 3 clinical studies of myeloma therapies. Adam has been the Principle Investigator of several myeloma trials and is an active member of the Australia Leukaemia and Lymphoma Group Myeloma Working Party.
His major other role is as Chair of the rapidly expanding Haematology Clinical Trials Unit of South Western Sydney that aims to bring new and innovative therapies to the patients of this previously underserviced region. Adam has also had various roles with the NSW Cancer Institute, in particular as the Chair of the EviQ Haematology Reference Committee.
A/Prof Andrea Henden
Royal Brisbane and Women's Hospital
A/Prof Andrea Henden (BSc MBBS (Hons) FRACP FRCPA
PhD) is a clinical Haematologist and Bone Marrow Transplant physician at the
Royal Brisbane and Women's Hospital in Brisbane, Australia and a holder of a
Metro North Clinician Research Fellowship. She has a clinical interest in
transplantation and cellular therapies, and the infectious complications of
these treatments. A/Prof Henden is also a research officer in the Translational
Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute.
Her research focusses on transplant immunology and current active projects
include cellular therapies for infection, and the role of the microbiome and
metabolism on T cell function in the context of transplantation and cellular
therapy. She is the Principal Investigator on a number of Investigator
Initiated Clinical Trials bringing novel immunotherapies to the clinic, with a
focus toward treating complications of immunotherapies.
Dr Nicole Wong Doo
Clinical and laboratory haematologist
New South Wales
Dr Nicole Wong Doo (MBBS (Hons), PhD, FRACP, FRCPA, GradCert[ClinTch]) is a clinical and laboratory haematologist at Concord Repatriation General Hospital, senior lecturer at Concord Clinical School and Honorary Research Associate at the Cancer Council Victoria. As the Director of the Haematology Clinical Research Unit at Concord Hospital, she leads a team of 25 in the delivery of clinical trials embedded within clinical practice and clinical-translational research.Since completing a PhD in lymphoma and myeloma epigenetics at the University of Melbourne, she has built a growing portfolio of clinical research, as the Australianprincipal investigator of the ALLG HD13 RADAR trial in hodgkin lymphoma supported by the MRFF. She has ongoing research interests in lymphoma and multiple myeloma clinical trials and supportive care, including being a member of the ALLG Multiple Myeloma, Lymphoma and Supportive Care Scientific Working Parties, member of the Australasian Lymphoma Alliance and on the Steering Committee of the Australasian Myeloma Research Consortium. With a growing profile in patient-reported outcomes (PRO) research, she leads a PRO study in Oral therapy for Blood Diseases and is PI of a digital research project called MyHodgkin MyHealth, a mobile App for patient-entered health outcomes in Hodgkin lymphoma. Dr Wong Doo is dedicated to promoting excellence in Haematology in the Asia-Pacific region and works to deliver training and education as a member of the Royal College of Pathologists Australasia Pathology Education Outreach Committee (PEOC).
Dr Sumita Ratnasingam
University Hospital Geelong
Sumi Ratnasingam (AdvDipMedSci, BMedSci, MBBS, FRACP, FRCPA, GCertCncrSc) is a clinical haematologist from University Hospital Geelong in Victoria. She graduated from the University of Melbourne and completed a dual pathology/ clinical haematology fellowship in 2014. Sumi has a clinical interest in malignant haematology, particularly clinical trials and is the principal investigator for several lymphoma trials at Andrew Love Cancer Centre. She is an active member of the Australasian Lymphoma Alliance (ALA) and the Lymphoma Scientific Working Party. Sumi hopes as a council member, she will be able to help increase the representation of colleagues at a national level – women, minority groups and those from regional centres. Sumi is also a senior clinician lecturer at Deakin University and a FRACP clinical examiner. She enjoys teaching and mentoring enthusiastic junior doctors and medical students. Outside of work, Sumi values spending time with her family and friends. She loves travelling, food blogging, watching arthouse movies, attending motor shows, playing music, and looking at art exhibits.
Dr Gareth Gregory Director of Haematology Monash Health Victoria
Gareth Gregory is Director of
Haematology Clinical Research at Monash Health, an NHMRC Emerging Leadership
Fellow at Monash University and past Victorian Cancer Agency Clinical Research
Fellow. Following Haematology training through Royal Perth Hospital, Alfred
Health and Monash Health, he completed a PhD investigating new treatments for
lymphoma at the Peter MacCallum Cancer Centre & University of Melbourne for
which he was awarded the HSANZ Baikie Medal. Gareth is passionate about
promoting research collaborations to improve outcomes for patients with blood
cancers, and to this end he is an alumnus of the European Hematology
Association Clinical Research Training in Hematology program, a member of the
Scientific Advisory Committee and Co-Chair of the Lymphoma Working Party of the
Australasian Leukaemia & Lymphoma Group, a founding Steering Committee
Member of the Australasian Lymphoma Alliance and a member of the Women in
Lymphoma Champions of Change committee promoting gender equality in academic
practice. Outside of work, Gareth enjoys time with his young family including
pathologically anxious cat and dog, running and sipping gin.
Dr Prudence (Pru) Smith
Pru Smith is a haematologist at Hobart Hospital
Stephanie Anderson Early Career Representative
Stephanie Anderson is the Early Career
representative for HSANZ. She is currently undertaking a PhD titled ‘Gene
editing to cure Sickle Cell Disease’ at the Australian Centre for Blood
Diseases and is a recipient of the HSANZ New Investigator Scholarship.
Stephanie undertook a Bachelor of Medical Science before graduating from
medicine at the University of Sydney. She has dual Fellowship of the Royal
Australasian College of Physicians and the Royal College of Pathologists of
Australasia. Stephanie is an avid hockey player, and enjoys taking her dog for
walks along St Kilda beach.
Andrew (Andy) Steele HSANZ Nurses Group Lead
Andy started working in Oncology upon qualification in 1991 in the UK. His first role in Haematology was 3 years later at Derriford Hospital, Plymouth, and he became Charge nurse there in 1998. In 2000, Andy moved to Kalgoorlie, WA, working in Restorative and Palliative care as a manager and stayed there for 2 years before moving to Perth to work on the Haematology ward, G73. He stayed there for 14 years night and day and then moved to the Haematology Day Ward as Clinical Nurse Specialist and then Manager in 2014. He has been a Nurses Representative for the HSANZ Nurses group WA since 2015 and became vice president of the national nurses group in 2020. Furthermore, he has an interest in Change Theory, presenting several times at Blood Conferences as well as organising and chairing the nurse’s stream of Blood 2019 in Perth. He has obtained a post grad certificate in Leading Great Care.
GENERAL MANAGER and
New South Wales
Valerie Orton is the General Manager and Company Secretary of HSANZ. She obtained her Bachelor of Arts in Psychology and Philosophy from the University of New South Wales and University of California Santa Barbara and Master of Applied Science in Social Ecology from Western Sydney University, Hawkesbury. With a business background, Valerie operated her consulting business for several years, focussing on coaching and training in ‘soft’ human skills. She has also managed two other Associations – Chief Executive Woman and Sustainable Business Australia. Her book Everyday Resilience – Creating Calm from Chaos is a bestseller (not really!), but it is a good practical book.
She started working with HSANZ in January 2020 and has enjoyed the challenge of bringing the Society into the new decade. While not sitting in front of a computer, she loves walking on the beach or in the mountains, practising her bass guitar and is writing another book.